Biolase, Inc. · OTC:BIOLQ

Biolase — Fifth Annual LD Micro Conference (December 2012)

20 slides from Biolase's conference presentation, Dec 6, 2012

  1. Slide 1: Fred Furry, COO & CFO

    PAGE 1 Fred Furry, COO & CFO December 6, 2012 Nasdaq: BIOL Exhibit 99.1

  2. Slide 2: Safe Harbor Statement

    PAGE 2 Safe Harbor Statement This presentation may contain forward-looking statements that are based on our current expectations, estimates and projections about our industry as well as management’s beliefs and assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “see

  3. Slide 3: BIOLASE Company Overview

    PAGE 3 We are a biomedical company focused on developing, manufacturing, and selling dental lasers using our revolutionary, proprietary WaterLase technology. Also a marketer & distributor of: – dental imaging equipment, – intra-oral scanners, and – other products designed for dental & medical proced

  4. Slide 4: BIOLASE's Total Technology Solution

    Step Technology BIOLASE Product Offering PAGE 4 Diagnose and establish treatment protocol 3D cone beam imaging NewTom (QR/Cefla) DaVinci Imaging (Cefla) Treatment: all tissue surgical device WaterLase WaterLase iPlus WaterLase MDX WaterLase MD Turbo Treatment: soft tissue surgical device Diode laser

  5. Slide 5: WaterLase is a biological method to cut tissue

    PAGE 5 WaterLase is a biological method to cut tissue. Water molecules within tissue absorb the laser energy from the WaterLase, expand, and vaporize, which causes a biological ablation of the tissue. – There is very little trauma or bleeding, – No heat or vibration are generated, and – Causes littl

  6. Slide 6: How It Works: WaterLase High Speed Cutting

    PAGE 6 How It Works: WaterLase High Speed Cutting

  7. Slide 7: WaterLase Side by Side with Drill

    PAGE 7 WaterLase Side by Side with Drill

  8. Slide 8: WaterLase Soft Tissue Lingual Frenectomy

    PAGE 8 WaterLase Soft Tissue Lingual Frenectomy

  9. Slide 9: WaterLase Atraumatic Pediatric Tooth Extraction

    PAGE 9 The WaterLase aiming beam does not cut the tissue or generate heat. The tissue is cut biologically, with little or no pain, when the laser energizes water at the molecular level. WaterLase Atraumatic Pediatric Tooth Extraction

  10. Slide 10: BIOLASE's Market Opportunity

    PAGE 10 176,000 dentists in US & Canada. 1.2M+ dentists in 134 countries. – rapid growth in emerging economies e.g. China, India & Indonesia. Current market penetration . – approx. 5.0% of dental practices in US. – approx. 1.5% worldwide. Each incremental 1% market penetration equals over $600M reve

  11. Slide 11: Dominant Market Position

    80% 45% Dominant Market Position Hard-tissue Dental Laser Market Total Dental Laser Market BIOLASE Market Share

  12. Slide 12: Diode Soft-Tissue Dental Lasers

    EPIC 10 total diode solution – regulatory clearance late Q3 (EU) & early Q4 (US) 2012. – cleared for 3 unique uses: Soft Tissue Surgery, Whitening, Pain Therapy. iLase – portable diode laser. – no foot pedal, power cord, or external controls. Diode Soft-Tissue Dental Lasers

  13. Slide 13: In-Licensed Products

    PAGE 13 In-Licensed Products NewTom and Cefla 3D cone beam imaging products – medical grade imaging technology. – less cost, less radiation exposure. – U.S. & Canada distribution agreement through Feb 2015. TRIOS intra-oral scanner and cart – digital impression taking. – handheld scanner, operator's

  14. Slide 14: Extensive Patent Portfolio

    Issued & Active Pending Total PAGE 14 291 patents issued & pending 70% are related to WaterLase technology & medical lasers Extensive Patent Portfolio U.S. International Total

  15. Slide 15: Sales and Marketing

    PAGE 15 Sales and Marketing Returned to direct sales model in N. America in August 2010 Currently consists of 47-person team: – 37 direct outside sales – 10 inside sales representatives and lead generators Targeted plans for 42-45 outside reps and 12-15 inside reps Global sales offices – Current: Ir

  16. Slide 16: Gross Revenue and Influencers

    PAGE 16 Gross Revenue and Influencers Launched Cefla’s NewTom Cone Beam Imaging products Introduced iLase™ hand-held soft- tissue diode laser Introduced DaVinci Imaging™ products Launched WaterLase ® iPlus™ all-tissue laser Launched 3Shape’s TRIOS™ intra-oral scanner CE Mark & FDA clearance for EPIC

  17. Slide 17: Growth Strategy

    PAGE 17 Continued adoption of core WaterLase products. Drive sales of EPIC 10 diode soft-tissue laser. Growth of Imaging Division (cone beam and cad-cam) Additional new product introductions based on our core technologies. – Two 510(k) submissions currently under FDA review. – Three additional submi

  18. Slide 18: Investment Considerations

    PAGE 18 Ongoing growth in WaterLase sales. Recent & planned new product introductions. – EPIC 10 & TRIOS introduced second half of 2012. – Additional product launches based on core technologies planned. Strong IP protection with additional patents pending. Addressing $50 dental laser market opportun

  19. Slide 19: BIOLASE Today

    PAGE 19 BIOLASE Corporate Headquarters in Irvine, California Over 180 employees worldwide Sales offices in Floss (Germany), Madrid (Spain), Shanghai (China), and Mumbai (India); expansion planned in Dubai (UAE), and Rio de Janero (Brazil) Floss also has service and manufacturing capabilities BIOLASE

  20. Slide 20: Fred Furry, COO & CFO contact

    PAGE 20 Fred Furry COO & CFO, BIOLASE, Inc. 949.226.8124 ffurry@biolase.net Lisa Wilson President, In-Site Communications, Inc. 212.759.3929 lwilson@insitecony.com

Biolase — Fifth Annual LD Micro Conference (December 2012) on 6ix